Methods of selecting T cell line and donor thereof for adoptive cellular therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11173205
APP PUB NO 20170319683A1
SERIAL NO

15523544

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods of selecting an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer. Also disclosed are methods of selecting a donor from whom to derive an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORIAL SLOAN KETTERING CANCER CENTER1275 YORK AVENUE NEW YORK NY 10065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Doubrovina, Ekaterina Bronx, US 11 43
Hasan, Aisha N Blue Bell, US 2 3
Koehne, Guenther New York, US 6 10
O'Reilly, Richard J Roxbury, US 5 80
Prockop, Susan E New York, US 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 16, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 May 16, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 16, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00